Nuvation Bio Inc. announced the appointment of Colleen Sjogren as Chief Commercial Officer. Ms. Sjogren will lead the Company?s commercial strategy and operations, including marketing, sales, and market access. Ms. Sjogren most recently served as the Senior Vice President of U.S. Sales at Madrigal Pharmaceuticals, where she developed the commercial sales launch plan for a first-in-class, first-to-market therapy.

Previously, she was the Vice President of U.S. Sales, Sales Training, and Meeting Planning at Mirati Therapeutics, where she led the build-out of the field-facing commercial organization for the company?s first targeted oncology product launch. Prior to that role, Ms. Sjogren was the Vice President of the National Cell Therapy Team/Sales and Commercial Operations at Kite Pharma, a Gilead company, and held senior leadership roles at Medivation, Human Genome Sciences, Genentech, and Centocor. She received her B.S. and B.A. from Bryant University.